文献速递腹部US

CEUS LI-RADS的病理学考量:与纤维化分期和肿瘤组织学分型的相关性

Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade.
PubMed 文献 · Eur Radiol · 2021-01-27

该回顾性研究纳入441例高危患者共460个病理证实的肝细胞癌,评估纤维化分期和组织学分级对CEUS LI-RADS v2017分类的影响。低级别组LR-5比例高于高级别组(151/280 vs 66/159,p=0.013),高级别组LR-TIV比例高于低级别组(36/159 vs 40/280,p=0.035)。纤维化分期影响≥2cm和低级别组的动脉期高增强,但不影响LI-RADS分类。

要点

  • 病理分级影响CEUS LI-RADS分类,低级别HCC更多归为LR-5,高级别更多归为LR-TIV。
  • 肝纤维化分期不影响CEUS LI-RADS分类,但影响≥2cm和低级别HCC的动脉期高增强。
  • CEUS LI-RADS在高级别和不同纤维化分期患者中诊断HCC可能可行。

核心结论

  • 肝纤维化分期可影响动脉期高增强,但对CEUS LI-RADS分类无影响;HCC组织学分级影响LR-5和LR-TIV分类。

研究设计与样本

  • 回顾性研究,2015年6月至2016年12月连续纳入441例高危患者共460个病理证实的HCC,均行CEUS检查,按CEUS LI-RADS v2017分类。

诊断标准与关键数值

  • 低级别组LR-5比例151/280高于高级别组66/159(p=0.013)。
  • 高级别组LR-TIV比例36/159高于低级别组40/280(p=0.035)。
  • 不同纤维化分期之间CEUS LI-RADS分类无显著差异(p≥0.05)。
  • 在≥2cm和低级别HCC中,动脉期高增强与肝纤维化分期显著相关(p=0.027和p=0.003)。
  • 低级别组与高级别组之间CEUS LI-RADS主要特征均无统计学显著差异(p≥0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the influence of pathological factors, such as fibrosis stage and histological grade, on the Liver Imaging Reporting and Data System (LI-RADS) v2017 category of contrast-enhanced ultrasonography (CEUS) in patients with high risk of hepatocellular carcinoma (HCC).

MATERIALS AND METHODS: Between June 2015 and December 2016, 441 consecutive patients at high risk of HCC with 460 pathologically proven HCCs were enrolled in this retrospective study. All patients underwent a CEUS examination. The major features (arterial phase hyperenhancement, late and mild washout) were assessed, and LI-RADS categories were assigned according to CEUS LI-RADS v2017. CEUS LI-RADS categories and major features were compared in different histological grades and fibrosis stages.

RESULTS: The CEUS LR-5 category was more frequently assigned in the low-grade group (151/280) than in the high-grade group (66/159) (p = 0.013), whereas the LR-TIV category was more frequently assigned in the high-grade group (36/159) than in the low-grade group (40/280) (p = 0.035). CEUS LI-RADS category was not significantly different among different fibrosis stages (p ≥ 0.05). Arterial phase hyperenhancement (APHE) and the hepatic fibrosis stage showed a significant correlation in HCCs ≥ 2 cm and the low-grade group (p = 0.027 and p = 0.003, respectively). No major features of CEUS LI-RADS showed statistically significant differences between the low- and high-grade groups (p ≥ 0.05).

CONCLUSION: Hepatic fibrosis stage can influence APHE but showed no impact on the CEUS LI-RADS classification, whereas the histological grade of HCC influenced the LR-5 and LR-TIV categories.

KEY POINTS: • Histological grade influenced CEUS LR-5 and LR-TIV category (p = 0.013 and p = 0.035 respectively). Low-grade HCCs occurred more frequently in LR-5 category whereas high-grade HCCs occurred more frequently in LR-TIV category. • Fibrosis stage shows significant influence on APHE on HCCs of the size ≥ 2 cm and low-grade group (p = 0.027 and p = 0.003, respectively). • Hepatic fibrosis stage and HCC histological grade exhibited limited impact on CEUS LI-RADS. CEUS LI-RADS may be feasible for diagnosing HCC in patients regardless of histological grade and fibrosis stage.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Cheng MQ, Hu HT, Huang H, et al. Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade. Eur Radiol. 2021. PMID: 33502556. doi:10.1007/s00330-020-07660-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。